Skip to Main Content

People

Co-Directors

  • Co-Director

    Dr. Pittenger is Professor and Assistant Chair for Translational Research in the Department of Psychiatry at Yale. He holds a Ph.D. in neurobiology, earned under the tutelage of Nobel Prize winning psychiatrist Eric Kandel. Dr. Pittenger has a long history of cutting-edge, collaborative, and trans-disciplinary research, which continues in this Center.
  • Co-Director

    Dr. Kelmendi is Assistant Professor of Psychiatry. He has been a key driver of psychedelic studies at Yale. He is as a co-founder of the Yale Psychedelic Science Interest Group, principal investigator (together with Dr. Pittenger) of the first controlled study of psilocybin in the treatment of obsessive-compulsive disorder, and a co-investigator on a major multi-site study of psilocybin in the treatment of depression, sponsored by the Usona Institute.  Dr. Kelmendi is on the Board of the Heffter Foundation, a major sponsor of work in psychedelic science.

Advisory Board

  • Vikram Sodhi ’92 Professor of Psychiatry; Director Schizophrenia Neuropharmacology Research Group at Yale (SNRGY); Director, Neurobiological Studies Unit, VACHS; Director, VA-CMHC Schizophrenia Research Clinic; Director, Yale Center for the Science of Cannabis and Cannabinoids ; Chair, Research and Development Committee, VA Connecticut Healthcare System

  • George D. and Esther S. Gross Professor of Psychiatry; Director, Yale Depression Research Program; Co-Director, Yale New Haven Hospital Interventional Psychiatry Service

  • Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry, of Neuroscience, and of Psychology; Co-Director, Yale Center for Clinical Investigation; Chair, Psychiatry; Physician-in-Chief of Psychiatry, Yale New Haven Hospital; Director: NIAAA Center for the Translational Neuroscience of Alcoholism; Director, Clinical Neuroscience Division, VA National Center for PTSD

Members

  • Vikram Sodhi ’92 Professor of Psychiatry; Director Schizophrenia Neuropharmacology Research Group at Yale (SNRGY); Director, Neurobiological Studies Unit, VACHS; Director, VA-CMHC Schizophrenia Research Clinic; Director, Yale Center for the Science of Cannabis and Cannabinoids ; Chair, Research and Development Committee, VA Connecticut Healthcare System

  • George D. and Esther S. Gross Professor of Psychiatry; Director, Yale Depression Research Program; Co-Director, Yale New Haven Hospital Interventional Psychiatry Service

  • Associate Professor Adjunct in Psychiatry; Adjunct Associate Professor of Law; Director, Clinical and Affective Neuroscience Lab

  • Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry, of Neuroscience, and of Psychology; Co-Director, Yale Center for Clinical Investigation; Chair, Psychiatry; Physician-in-Chief of Psychiatry, Yale New Haven Hospital; Director: NIAAA Center for the Translational Neuroscience of Alcoholism; Director, Clinical Neuroscience Division, VA National Center for PTSD

  • Assistant Professor of Psychiatry; Director, Yale Cocaine Research Clinic, Psychiatry; Inpatient Chief of the Clinical Neuroscience Research Unit (CNRU), Psychiatry; Medical Director, Forensic Drug Diversion Clinic (ForDD)

  • Assistant Professor of Psychiatry; Assistant Director for Training and Education for CNRU, Psychiatry; Assistant Clinical Unit Chief for CNRU, Psychiatry; Research Psychiatrist, VA National Center for PTSD

  • Steven M. Southwick Professor of Psychiatry and Professor in the Child Study Center and of Neuroscience; Director, Center of Excellence in Gambling Research; Director, Yale Program for Research on Impulsivity and Impulse Control Disorders; Director, Women and Addictive Disorders, Women's Health Research at Yale